ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (28)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bresser, P.
Right arrow Articles by Rubin, L.J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bresser, P.
Right arrow Articles by Rubin, L.J.
Eur Respir J 2004; 23:595-600
Copyright ©ERS Journals Ltd 2004


Continuous intravenous epoprostenol for chronic thromboembolic pulmonary hypertension

P. Bresser1, P.F. Fedullo2, W.R. Auger2, R.N. Channick2, I.M. Robbins4, K.M. Kerr2, S.W. Jamieson3 and L.J. Rubin2

1 Dept of Pulmonology, Academic Medical Centre, Amsterdam, the Netherlands. 2 Division of Pulmonary and Critical Care Medicine, 3 Division of Cardiothoracic Surgery, University of California San Diego, San Diego, CA, and 4 Division of Allergy, Pulmonology and Critical Care Medicine, Vanderbilt University School of Medicine, Nashville, USA

CORRESPONDENCE: P. Bresser, Academic Medical Centre, University of Amsterdam, Dept of Pulmonology, F5-162, PO Box 22700, 1100 DE Amsterdam, the Netherlands. Fax: 31 20691784. E-mail: p.bresser@amc.uva.nl

Keywords: chronic thromboembolic pulmonary hypertension, epoprostenol, pulmonary thromboendartectomy, right heart failure

Received: February 23, 2003
Accepted November 3, 2003

I.M. Robbins was supported by NIH grant RR 15534.

Pathophysiological findings in chronic thromboembolic pulmonary hypertension (CTEPH) have suggested that a secondary small vessel arteriopathy may contribute to the haemodynamic impairment observed in these patients. It was hypothesised that this element of the elevated vascular resistance may be responsive to continuous intravenous epoprostenol therapy.

Retrospectively, the clinical and haemodynamic responses to continuous intravenous epoprostenol were evaluated in nine CTEPH patients who subsequently underwent pulmonary thromboendarterectomy (PTE). Cardiopulmonary haemodynamics were determined prior to the initiation of epoprostenol, while on epoprostenol, prior to PTE, and after PTE.

Six patients, treated for 2–26 months prior to PTE, experienced either clinical stability or improvement that was associated with a mean reduction in pulmonary vascular resistance (PVR) of 28% (median 33%, range 0–46%). Three patients, treated for 3–9 months, experienced clinical deterioration during epoprostenol administration, with a significant increase in PVR in two patients. Subsequent PTE resulted in a highly significant improvement of cardiac index, mean pulmonary artery pressure and total pulmonary resistance.

To conclude, selected patients with chronic thromboembolic pulmonary hypertension may benefit clinically and haemodynamically from continuous intravenous epoprostenol treatment prior to pulmonary thromboendarterectomy. Factors predictive of a beneficial response, and whether this intervention influences either morbidity or mortality associated with pulmonary thromboendarterectomy, remain to be established.




This article has been cited by other articles:


Home page
HeartHome page
National Pulmonary Hypertension Centres of the UK
Consensus statement on the management of pulmonary hypertension in clinical practice in the UK and Ireland
Heart, March 1, 2008; 94(Suppl_1): i1 - i41.
[Full Text] [PDF]


Home page
ThoraxHome page
National Pulmonary Hypertension Centres of the UK
Consensus statement on the management of pulmonary hypertension in clinical practice in the UK and Ireland
Thorax, March 1, 2008; 63(Suppl_2): ii1 - ii41.
[Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
H. J. Reesink, I. I. Tulevski, J. T. Marcus, F. Boomsma, J. J. Kloek, A. Vonk Noordegraaf, and P. Bresser
Brain Natriuretic Peptide as Noninvasive Marker of the Severity of Right Ventricular Dysfunction in Chronic Thromboembolic Pulmonary Hypertension
Ann. Thorac. Surg., August 1, 2007; 84(2): 537 - 543.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
H. A. Ghofrani, R. Voswinckel, F. Reichenberger, N. Weissmann, R. T. Schermuly, W. Seeger, and F. Grimminger
Hypoxia- and non-hypoxia-related pulmonary hypertension - Established and new therapies
Cardiovasc Res, October 1, 2006; 72(1): 30 - 40.
[Abstract] [Full Text] [PDF]


Home page
Proc Am Thorac SocHome page
P. Bresser, J. Pepke-Zaba, X. Jais, M. Humbert, and M. M. Hoeper
Medical Therapies for Chronic Thromboembolic Pulmonary Hypertension: An Evolving Treatment Paradigm
Proceedings of the ATS, September 1, 2006; 3(7): 594 - 600.
[Abstract] [Full Text] [PDF]


Home page
Proc Am Thorac SocHome page
L. J. Rubin, M. M. Hoeper, W. Klepetko, N. Galie, I. M. Lang, and G. Simonneau
Current and Future Management of Chronic Thromboembolic Pulmonary Hypertension: From Diagnosis to Treatment Responses
Proceedings of the ATS, September 1, 2006; 3(7): 601 - 607.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
R. J. Hughes, X. Jais, D. Bonderman, J. Suntharalingam, M. Humbert, I. Lang, G. Simonneau, and J. Pepke-Zaba
The efficacy of bosentan in inoperable chronic thromboembolic pulmonary hypertension: a 1-year follow-up study
Eur. Respir. J., July 1, 2006; 28(1): 138 - 143.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. M. Hoeper, E. Mayer, G. Simonneau, and L. J. Rubin
Chronic Thromboembolic Pulmonary Hypertension
Circulation, April 25, 2006; 113(16): 2011 - 2020.
[Full Text] [PDF]


Home page
ChestHome page
C. Strange
Treatment for Secondary Pulmonary Hypertension
Chest, October 1, 2005; 128(4): 1897 - 1898.
[Full Text] [PDF]


Home page
ChestHome page
M. M. Hoeper, T. Kramm, H. Wilkens, C. Schulze, H. J. Schafers, T. Welte, and E. Mayer
Bosentan Therapy for Inoperable Chronic Thromboembolic Pulmonary Hypertension
Chest, October 1, 2005; 128(4): 2363 - 2367.
[Abstract] [Full Text] [PDF]


Home page
Vasc MedHome page
F. Kipfmueller, R. Quiroz, S. Z Goldhaber, U J. Schoepf, P. Costello, and N. Kucher
Chest CT assessment following thrombolysis or surgical embolectomy for acute pulmonary embolism
Vascular Medicine, May 1, 2005; 10(2): 85 - 89.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the European Respiratory Society.